NDC 67296-1818
Tivicay 50 mg tablet, film coated
On the label: RedPharm Drug. Inc.. It's repackaged: RedPharm Drug. Inc. rebottles it from ViiV Healthcare Company's NDC 49702-228.
Where the pills inside were made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants ViiV Healthcare Company names for other drugs.
Repackaging site
- RedPharm Drug, Eden Prairie, MN, United States · repackages it
Recalls
- May 13, 2022 · Class III · GlaxoSmithKline LLC
Labeling: incorrect or missing lot and/or expiration date. An incorrect expiration date was printed on the product labeling with an expiration date of January 2027, whereas the correct expiration date is September 2026.
Lots: Lot: 2A9E, Exp 1/2027 - Feb 11, 2014 · Class III · Viiv Healthcare Company
Cross Contamination with Other Products: Product contains Promacta (eltrombopag).
Lots: Lot #: 3ZP2210 Sub-lot A, Expiry: 10/15
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Dolutegravir: every company that makes it
- Form
- tablet, film coated
- Strength
- 50 mg
- Approval
- NDA NDA204790
- On the market since
- Aug 13, 2013
- Package NDCs
67296-1818-367296-1818-567296-1818-7- Official label
- DailyMed (National Library of Medicine), updated Jul 18, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?